IRONWOOD PHARMACEUTICALS, INC. (IRWD) Operating margin 2016–2025
IRONWOOD PHARMACEUTICALS, INC. (IRWD) operating margin by fiscal year — reported operating income divided by reported revenue.
33.3%FY2025 · since FY2016: -18.9% → 33.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 33.3% | +6.8 pp |
| FY2024 | 26.5% | +240.0 pp |
| FY2023 | -213.5% | -274.5 pp |
| FY2022 | 61.0% | +4.8 pp |
| FY2021 | 56.1% | +19.4 pp |
| FY2020 | 36.7% | +8.7 pp |
| FY2019 | 28.0% | +71.5 pp |
| FY2018 | -43.5% | -38.3 pp |
| FY2017 | -5.2% | +13.8 pp |
| FY2016 | -18.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IRWD financial trends
IRWD RevenueIRWD Net incomeIRWD Net marginIRWD Gross profitIRWD Gross marginIRWD Operating incomeIRWD Operating cash flowIRWD Free cash flowIRWD Capital expendituresIRWD Return on equityIRWD Stock buybacksIRWD Dividends paidIRWD Total assetsIRWD Total liabilitiesIRWD Shareholders’ equityIRWD overview →